25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

EstechPharma Co. Ltd
Buy, Hold or Sell?

Let's analyze Estechpharma together

I guess you are interested in EstechPharma Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of EstechPharma Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about EstechPharma Co. Ltd

I send you an email if I find something interesting about EstechPharma Co. Ltd.

1. Quick Overview

1.1. Quick analysis of Estechpharma (30 sec.)










1.2. What can you expect buying and holding a share of Estechpharma? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
75.0%

What is your share worth?

Current worth
₩9,706.12
Expected worth in 1 year
₩9,197.38
How sure are you?
77.5%

+ What do you gain per year?

Total Gains per Share
₩-508.73
Return On Investment
-8.7%

For what price can you sell your share?

Current Price per Share
₩5,840.00
Expected price per share
₩5,010 - ₩6,650
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Estechpharma (5 min.)




Live pricePrice per Share (EOD)
₩5,840.00

2.2. Growth of Estechpharma (5 min.)




Is Estechpharma growing?

Current yearPrevious yearGrowGrow %
How rich?$84.7m$83.1m-$820.4k-1.0%

How much money is Estechpharma making?

Current yearPrevious yearGrowGrow %
Making money$160.1k-$324.4k$484.5k302.6%
Net Profit Margin1.7%-3.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Estechpharma (5 min.)




2.4. Comparing to competitors in the Pharmaceuticals industry (5 min.)




  Industry Rankings (Pharmaceuticals)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Estechpharma?

Welcome investor! Estechpharma's management wants to use your money to grow the business. In return you get a share of Estechpharma.

First you should know what it really means to hold a share of Estechpharma. And how you can make/lose money.

Speculation

The Price per Share of Estechpharma is ₩5,840. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Estechpharma.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Estechpharma, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩9,706.12. Based on the TTM, the Book Value Change Per Share is ₩-127.18 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-56.90 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Estechpharma.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.140.0%0.010.0%-0.030.0%0.060.0%0.080.0%
Usd Book Value Change Per Share-0.010.0%-0.090.0%-0.040.0%0.040.0%0.070.0%
Usd Dividend Per Share0.000.0%0.000.0%0.050.0%0.050.0%0.040.0%
Usd Total Gains Per Share-0.010.0%-0.090.0%0.010.0%0.090.0%0.110.0%
Usd Price Per Share5.41-5.55-5.17-6.51-8.07-
Price to Earnings Ratio9.62--4.33-8.57-1.98-24.26-
Price-to-Total Gains Ratio-610.82--153.41-48.90--209.34--65.03-
Price to Book Ratio0.80-0.80-0.73-0.95-1.51-
Price-to-Total Gains Ratio-610.82--153.41-48.90--209.34--65.03-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.088
Number of shares244
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.05
Usd Book Value Change Per Share-0.090.04
Usd Total Gains Per Share-0.090.09
Gains per Quarter (244 shares)-21.7222.34
Gains per Year (244 shares)-86.8989.35
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-87-97474379
20-174-1849385168
30-261-271140128257
40-348-358187170346
50-434-445234213435
60-521-532280256524
70-608-619327298613
80-695-706374341702
90-782-793421383791
100-869-880467426880

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%7.05.00.058.3%15.05.00.075.0%29.06.05.072.5%30.06.06.071.4%
Book Value Change Per Share1.03.00.025.0%6.06.00.050.0%14.06.00.070.0%29.011.00.072.5%30.012.00.071.4%
Dividend per Share0.00.04.00.0%7.00.05.058.3%15.00.05.075.0%30.00.010.075.0%30.00.012.071.4%
Total Gains per Share1.03.00.025.0%7.05.00.058.3%15.05.00.075.0%31.09.00.077.5%32.010.00.076.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of EstechPharma Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---12.655-127.184+905%-56.898+350%62.366-120%101.045-113%
Book Value Per Share--9706.1169907.317-2%10173.861-5%9803.819-1%8321.269+17%
Current Ratio--11.25411.487-2%9.790+15%9.010+25%5.613+100%
Debt To Asset Ratio--0.0660.061+9%0.0660%0.081-18%0.140-53%
Debt To Equity Ratio--0.0710.065+9%0.0710%0.089-20%0.174-59%
Dividend Per Share----0%75.000-100%68.417-100%52.167-100%
Eps--200.85916.148+1144%-39.683+120%92.597+117%117.229+71%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.875+14%
Market Cap68211200000.000-41%96470446380.00094080847535.000+3%86286073875.000+12%108880689297.000-11%135242132223.500-29%
Net Profit Margin--0.1670.017+886%-0.038+123%0.072+131%0.114+46%
Operating Margin----0%0.015-100%0.055-100%0.038-100%
Operating Ratio--1.4901.709-13%1.187+25%1.069+39%1.096+36%
Pb Ratio0.602-32%0.7960.803-1%0.727+10%0.955-17%1.506-47%
Pe Ratio7.269-32%9.621-4.334+145%8.566+12%1.982+386%24.257-60%
Price Per Share5840.000-32%7730.0007922.500-2%7387.500+5%9295.500-17%11524.500-33%
Price To Free Cash Flow Ratio---134.212-100%-4.4690%19.088-100%10.295-100%
Price To Total Gains Ratio-461.472+24%-610.819-153.414-75%48.902-1349%-209.337-66%-65.026-89%
Quick Ratio---2.926-100%6.812-100%5.869-100%3.341-100%
Return On Assets--0.0190.002+1184%-0.004+121%0.009+117%0.012+58%
Return On Equity--0.0210.002+1189%-0.004+121%0.010+109%0.015+40%
Total Gains Per Share---12.655-127.184+905%18.102-170%130.783-110%153.211-108%
Usd Book Value--84792670.20082361121.904+3%83181559.538+2%80427838.702+5%68373492.190+24%
Usd Book Value Change Per Share---0.009-0.089+905%-0.040+350%0.044-120%0.071-113%
Usd Book Value Per Share--6.7946.935-2%7.122-5%6.863-1%5.825+17%
Usd Dividend Per Share----0%0.052-100%0.048-100%0.037-100%
Usd Eps--0.1410.011+1144%-0.028+120%0.065+117%0.082+71%
Usd Free Cash Flow---577290.382-100%-1359483.9060%-102051.5110%1110494.089-100%
Usd Market Cap47747840.000-41%67529312.46665856593.275+3%60400251.713+12%76216482.508-11%94669492.556-29%
Usd Price Per Share4.088-32%5.4115.546-2%5.171+5%6.507-17%8.067-33%
Usd Profit--1754702.600160145.409+996%-324449.001+118%762700.700+130%964106.931+82%
Usd Revenue--10519103.00010539051.9760%10875404.904-3%10685012.000-2%8983698.374+17%
Usd Total Gains Per Share---0.009-0.089+905%0.013-170%0.092-110%0.107-108%
 EOD+4 -3MRQTTM+17 -11YOY+15 -145Y+13 -1710Y+18 -14

3.3 Fundamental Score

Let's check the fundamental score of EstechPharma Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-157.269
Price to Book Ratio (EOD)Between0-10.602
Net Profit Margin (MRQ)Greater than00.167
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than111.254
Debt to Asset Ratio (MRQ)Less than10.066
Debt to Equity Ratio (MRQ)Less than10.071
Return on Equity (MRQ)Greater than0.150.021
Return on Assets (MRQ)Greater than0.050.019
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of EstechPharma Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.283
Ma 20Greater thanMa 505,721.000
Ma 50Greater thanMa 1006,379.400
Ma 100Greater thanMa 2006,883.100
OpenGreater thanClose5,930.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About EstechPharma Co. Ltd

EstechPharma Co., Ltd. manufactures and sells pharmaceuticals products. It also offers raw materials, such as RBM and PLK. The company was formerly known as Estech Chemical and changed its name to EstechPharma Co., Ltd. in January 2001. EstechPharma Co., Ltd. was founded in 1996 and is headquartered in Hwaseong-si, South Korea.

Fundamental data was last updated by Penke on 2024-11-18 14:08:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Estechpharma earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Estechpharma to the Pharmaceuticals industry mean.
  • A Net Profit Margin of 16.7% means that ₩0.17 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of EstechPharma Co. Ltd:

  • The MRQ is 16.7%. The company is making a huge profit. +2
  • The TTM is 1.7%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ16.7%TTM1.7%+15.0%
TTM1.7%YOY-3.8%+5.5%
TTM1.7%5Y7.2%-5.5%
5Y7.2%10Y11.4%-4.2%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ16.7%9.8%+6.9%
TTM1.7%9.5%-7.8%
YOY-3.8%9.9%-13.7%
5Y7.2%12.9%-5.7%
10Y11.4%12.6%-1.2%
4.3.1.2. Return on Assets

Shows how efficient Estechpharma is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Estechpharma to the Pharmaceuticals industry mean.
  • 1.9% Return on Assets means that Estechpharma generated ₩0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of EstechPharma Co. Ltd:

  • The MRQ is 1.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 0.2%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.9%TTM0.2%+1.8%
TTM0.2%YOY-0.4%+0.6%
TTM0.2%5Y0.9%-0.7%
5Y0.9%10Y1.2%-0.3%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9%3.6%-1.7%
TTM0.2%3.5%-3.3%
YOY-0.4%5.3%-5.7%
5Y0.9%5.9%-5.0%
10Y1.2%4.9%-3.7%
4.3.1.3. Return on Equity

Shows how efficient Estechpharma is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Estechpharma to the Pharmaceuticals industry mean.
  • 2.1% Return on Equity means Estechpharma generated ₩0.02 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of EstechPharma Co. Ltd:

  • The MRQ is 2.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.1%TTM0.2%+1.9%
TTM0.2%YOY-0.4%+0.6%
TTM0.2%5Y1.0%-0.8%
5Y1.0%10Y1.5%-0.5%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1%4.6%-2.5%
TTM0.2%4.6%-4.4%
YOY-0.4%8.2%-8.6%
5Y1.0%9.1%-8.1%
10Y1.5%10.3%-8.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of EstechPharma Co. Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Estechpharma is operating .

  • Measures how much profit Estechpharma makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Estechpharma to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of EstechPharma Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY1.5%-1.5%
TTM-5Y5.5%-5.5%
5Y5.5%10Y3.8%+1.7%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.2%-13.2%
TTM-12.0%-12.0%
YOY1.5%12.4%-10.9%
5Y5.5%8.6%-3.1%
10Y3.8%12.1%-8.3%
4.3.2.2. Operating Ratio

Measures how efficient Estechpharma is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 1.49 means that the operating costs are ₩1.49 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of EstechPharma Co. Ltd:

  • The MRQ is 1.490. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.709. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.490TTM1.709-0.219
TTM1.709YOY1.187+0.521
TTM1.7095Y1.069+0.640
5Y1.06910Y1.096-0.028
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4901.225+0.265
TTM1.7091.220+0.489
YOY1.1871.311-0.124
5Y1.0691.249-0.180
10Y1.0961.240-0.144
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of EstechPharma Co. Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Estechpharma is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 11.25 means the company has ₩11.25 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of EstechPharma Co. Ltd:

  • The MRQ is 11.254. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.487. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ11.254TTM11.487-0.233
TTM11.487YOY9.790+1.698
TTM11.4875Y9.010+2.477
5Y9.01010Y5.613+3.397
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ11.2542.213+9.041
TTM11.4872.234+9.253
YOY9.7902.028+7.762
5Y9.0102.199+6.811
10Y5.6131.995+3.618
4.4.3.2. Quick Ratio

Measures if Estechpharma is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Estechpharma to the Pharmaceuticals industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of EstechPharma Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.926-2.926
TTM2.926YOY6.812-3.886
TTM2.9265Y5.869-2.942
5Y5.86910Y3.341+2.527
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.926-0.926
TTM2.9260.973+1.953
YOY6.8121.515+5.297
5Y5.8691.591+4.278
10Y3.3411.399+1.942
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of EstechPharma Co. Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Estechpharma assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Estechpharma to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.07 means that Estechpharma assets are financed with 6.6% credit (debt) and the remaining percentage (100% - 6.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of EstechPharma Co. Ltd:

  • The MRQ is 0.066. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.061. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.066TTM0.061+0.005
TTM0.061YOY0.066-0.006
TTM0.0615Y0.081-0.020
5Y0.08110Y0.140-0.059
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0660.345-0.279
TTM0.0610.339-0.278
YOY0.0660.333-0.267
5Y0.0810.315-0.234
10Y0.1400.339-0.199
4.5.4.2. Debt to Equity Ratio

Measures if Estechpharma is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Estechpharma to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 7.1% means that company has ₩0.07 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of EstechPharma Co. Ltd:

  • The MRQ is 0.071. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.065. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.071TTM0.065+0.006
TTM0.065YOY0.071-0.006
TTM0.0655Y0.089-0.024
5Y0.08910Y0.174-0.084
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0710.547-0.476
TTM0.0650.547-0.482
YOY0.0710.499-0.428
5Y0.0890.476-0.387
10Y0.1740.548-0.374
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Estechpharma generates.

  • Above 15 is considered overpriced but always compare Estechpharma to the Pharmaceuticals industry mean.
  • A PE ratio of 9.62 means the investor is paying ₩9.62 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of EstechPharma Co. Ltd:

  • The EOD is 7.269. Based on the earnings, the company is cheap. +2
  • The MRQ is 9.621. Based on the earnings, the company is underpriced. +1
  • The TTM is -4.334. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD7.269MRQ9.621-2.352
MRQ9.621TTM-4.334+13.955
TTM-4.334YOY8.566-12.900
TTM-4.3345Y1.982-6.316
5Y1.98210Y24.257-22.275
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD7.26928.107-20.838
MRQ9.62129.844-20.223
TTM-4.33427.532-31.866
YOY8.56623.102-14.536
5Y1.98227.577-25.595
10Y24.25729.248-4.991
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of EstechPharma Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM134.212-134.212
TTM134.212YOY-4.469+138.681
TTM134.2125Y19.088+115.124
5Y19.08810Y10.295+8.793
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.531-29.531
TTM134.21229.447+104.765
YOY-4.46926.360-30.829
5Y19.08831.734-12.646
10Y10.29534.357-24.062
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Estechpharma is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 0.80 means the investor is paying ₩0.80 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of EstechPharma Co. Ltd:

  • The EOD is 0.602. Based on the equity, the company is cheap. +2
  • The MRQ is 0.796. Based on the equity, the company is cheap. +2
  • The TTM is 0.803. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.602MRQ0.796-0.195
MRQ0.796TTM0.803-0.006
TTM0.803YOY0.727+0.076
TTM0.8035Y0.955-0.152
5Y0.95510Y1.506-0.551
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD0.6024.674-4.072
MRQ0.7963.381-2.585
TTM0.8033.209-2.406
YOY0.7272.597-1.870
5Y0.9553.278-2.323
10Y1.5064.179-2.673
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets129,733,755
Total Liabilities8,601,369
Total Stockholder Equity121,132,386
 As reported
Total Liabilities 8,601,369
Total Stockholder Equity+ 121,132,386
Total Assets = 129,733,755

Assets

Total Assets129,733,755
Total Current Assets80,681,579
Long-term Assets49,052,175
Total Current Assets
Total Current Assets  (as reported)80,681,579
Total Current Assets  (calculated)0
+/- 80,681,579
Long-term Assets
Long-term Assets  (as reported)49,052,175
Long-term Assets  (calculated)0
+/- 49,052,175

Liabilities & Shareholders' Equity

Total Current Liabilities7,169,095
Long-term Liabilities1,432,274
Total Stockholder Equity121,132,386
Total Current Liabilities
Total Current Liabilities  (as reported)7,169,095
Total Current Liabilities  (calculated)0
+/- 7,169,095
Long-term Liabilities
Long-term Liabilities  (as reported)1,432,274
Long-term Liabilities  (calculated)0
+/- 1,432,274
Total Stockholder Equity
Total Stockholder Equity (as reported)121,132,386
Total Stockholder Equity (calculated)0
+/- 121,132,386
Other
Common Stock Shares Outstanding 12,480
Net Working Capital 73,512,484



6.2. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
> Total Assets 
103,233,399
103,026,765
102,964,634
114,555,068
107,773,570
108,761,085
99,824,744
91,363,579
93,349,557
93,985,266
93,177,912
97,473,231
97,498,880
97,604,545
99,284,085
96,850,991
100,320,604
105,277,645
100,750,951
98,344,936
100,896,841
110,600,269
115,888,873
116,425,611
117,842,030
120,191,316
119,781,087
123,148,774
123,506,432
125,504,936
125,670,890
134,360,827
136,003,025
131,515,401
132,397,965
124,319,008
126,106,633
126,290,677
126,500,304
121,898,738
122,981,055
129,733,755
129,733,755122,981,055121,898,738126,500,304126,290,677126,106,633124,319,008132,397,965131,515,401136,003,025134,360,827125,670,890125,504,936123,506,432123,148,774119,781,087120,191,316117,842,030116,425,611115,888,873110,600,269100,896,84198,344,936100,750,951105,277,645100,320,60496,850,99199,284,08597,604,54597,498,88097,473,23193,177,91293,985,26693,349,55791,363,57999,824,744108,761,085107,773,570114,555,068102,964,634103,026,765103,233,399
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
47,743,105
49,542,824
45,284,192
50,295,319
50,814,898
46,830,732
46,697,023
49,608,565
62,181,284
66,306,238
66,070,801
66,644,078
71,217,947
71,012,958
70,320,881
72,701,285
75,678,769
76,395,955
84,163,822
68,079,451
66,163,015
68,062,915
67,730,983
69,989,080
63,751,245
64,259,638
64,341,814
67,872,261
80,681,579
80,681,57967,872,26164,341,81464,259,63863,751,24569,989,08067,730,98368,062,91566,163,01568,079,45184,163,82276,395,95575,678,76972,701,28570,320,88171,012,95871,217,94766,644,07866,070,80166,306,23862,181,28449,608,56546,697,02346,830,73250,814,89850,295,31945,284,19249,542,82447,743,1050000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
25,280,351
26,311,925
21,468,355
9,171,198
27,971,108
23,555,933
23,927,247
26,139,402
38,879,918
42,350,413
38,555,256
40,160,741
40,443,285
41,483,107
40,306,087
41,906,958
42,880,488
28,454,985
1,174,327
1,730,835
1,766,216
8,253
8,536
7,174
10,562
18,467,984
22,776,703
23,266,958
0
023,266,95822,776,70318,467,98410,5627,1748,5368,2531,766,2161,730,8351,174,32728,454,98542,880,48841,906,95840,306,08741,483,10740,443,28540,160,74138,555,25642,350,41338,879,91826,139,40223,927,24723,555,93327,971,1089,171,19821,468,35526,311,92525,280,3510000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
59,873
0
0
17,659,400
0
0
0
0
0
0
0
0
0
0
10,854,560
0
0
15,047,899
4,790,965
14,297,511
3,246,336
12,025,836
0
0
8,827,598
8,858,684
4,677,422
6,303,026
0
06,303,0264,677,4228,858,6848,827,5980012,025,8363,246,33614,297,5114,790,96515,047,8990010,854,560000000000017,659,4000059,8730000000000000
       Net Receivables 
14,088,232
10,882,148
12,140,261
15,308,195
10,753,999
10,905,427
12,906,894
8,576,312
10,156,832
11,126,875
8,458,764
10,374,190
9,296,687
7,475,229
7,685,000
9,020,418
8,840,895
8,456,830
8,692,040
9,429,838
7,749,164
8,496,948
8,216,325
11,637,328
12,129,430
13,894,735
14,268,343
12,649,708
12,138,351
14,338,606
12,288,149
15,443,516
18,181,880
14,347,700
16,807,989
14,574,971
14,734,281
15,275,925
14,574,847
16,062,818
15,289,428
0
015,289,42816,062,81814,574,84715,275,92514,734,28114,574,97116,807,98914,347,70018,181,88015,443,51612,288,14914,338,60612,138,35112,649,70814,268,34313,894,73512,129,43011,637,3288,216,3258,496,9487,749,1649,429,8388,692,0408,456,8308,840,8959,020,4187,685,0007,475,2299,296,68710,374,1908,458,76411,126,87510,156,8328,576,31212,906,89410,905,42710,753,99915,308,19512,140,26110,882,14814,088,232
       Other Current Assets 
822,691
652,924
859,270
764,415
655,764
959,660
1,060,689
968,112
605,465
620,927
3,133,675
347,732
712,263
556,841
782,068
1,778,248
615,732
285,414
324,758
196,684
168,453
222,300
269,504
50,283
109,566
32,358
19,883
23,590
58,530
65,250
50,619
147,995
90,139
86,302
87,858
0
0
0
0
-1
0
0
00-1000087,85886,30290,139147,99550,61965,25058,53023,59019,88332,358109,56650,283269,504222,300168,453196,684324,758285,414615,7321,778,248782,068556,841712,263347,7323,133,675620,927605,465968,1121,060,689959,660655,764764,415859,270652,924822,691
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
56,117,553
62,539,432
62,240,666
57,556,924
55,108,793
49,052,175
49,052,17555,108,79357,556,92462,240,66662,539,43256,117,553000000000000000000000000000000000000
       Property Plant Equipment 
45,839,219
45,403,384
44,668,027
43,992,360
43,522,967
43,009,081
43,495,410
42,997,878
42,611,842
42,077,449
39,199,009
38,338,424
37,496,332
36,728,616
36,047,728
35,442,975
34,832,710
34,294,003
33,786,245
33,201,757
32,869,843
33,076,964
32,623,730
32,563,713
31,995,318
32,191,142
32,277,079
31,951,545
32,015,582
31,768,180
31,447,615
31,305,509
31,475,589
31,526,669
31,616,611
31,138,168
30,980,898
30,880,597
30,704,592
30,591,542
30,268,336
0
030,268,33630,591,54230,704,59230,880,59730,980,89831,138,16831,616,61131,526,66931,475,58931,305,50931,447,61531,768,18032,015,58231,951,54532,277,07932,191,14231,995,31832,563,71332,623,73033,076,96432,869,84333,201,75733,786,24534,294,00334,832,71035,442,97536,047,72836,728,61637,496,33238,338,42439,199,00942,077,44942,611,84242,997,87843,495,41043,009,08143,522,96743,992,36044,668,02745,403,38445,839,219
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
7,006,226
7,508,117
10,435,020
10,288,420
15,822,652
15,930,294
15,872,031
15,872,031
12,821,680
12,678,460
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000012,678,46012,821,68015,872,03115,872,03115,930,29415,822,65210,288,42010,435,0207,508,1177,006,2260000000000000
       Intangible Assets 
1,198,403
1,165,208
1,134,356
1,113,348
1,113,103
1,081,983
1,311,233
1,265,749
1,231,582
1,210,319
1,166,577
1,128,210
1,124,135
1,102,361
1,225,057
2,454,769
2,353,827
2,310,314
2,273,218
2,239,015
2,209,154
2,177,994
3,936,447
4,090,521
4,216,621
4,231,920
2,981,915
1,937,400
1,914,370
1,891,291
1,907,904
1,892,422
1,869,581
1,863,304
840,026
885,708
862,161
838,760
909,453
881,258
861,699
0
0861,699881,258909,453838,760862,161885,708840,0261,863,3041,869,5811,892,4221,907,9041,891,2911,914,3701,937,4002,981,9154,231,9204,216,6214,090,5213,936,4472,177,9942,209,1542,239,0152,273,2182,310,3142,353,8272,454,7691,225,0571,102,3611,124,1351,128,2101,166,5771,210,3191,231,5821,265,7491,311,2331,081,9831,113,1031,113,3481,134,3561,165,2081,198,403
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000
> Total Liabilities 
35,147,066
36,867,486
35,258,702
38,567,246
31,994,125
31,562,600
22,505,846
19,236,949
19,735,781
19,409,540
19,066,557
20,049,617
19,355,431
18,341,444
19,371,378
12,988,341
14,434,993
15,693,959
11,303,929
9,093,985
11,767,998
11,801,525
14,310,693
13,705,262
14,075,591
11,851,064
9,117,807
11,755,493
10,825,547
10,419,171
8,342,257
11,062,037
12,846,659
9,547,552
9,180,695
8,229,891
9,399,381
6,981,118
6,145,740
6,266,011
9,465,749
8,601,369
8,601,3699,465,7496,266,0116,145,7406,981,1189,399,3818,229,8919,180,6959,547,55212,846,65911,062,0378,342,25710,419,17110,825,54711,755,4939,117,80711,851,06414,075,59113,705,26214,310,69311,801,52511,767,9989,093,98511,303,92915,693,95914,434,99312,988,34119,371,37818,341,44419,355,43120,049,61719,066,55719,409,54019,735,78119,236,94922,505,84631,562,60031,994,12538,567,24635,258,70236,867,48635,147,066
   > Total Current Liabilities 
21,039,852
23,017,079
25,259,990
36,410,116
29,878,715
29,324,728
14,391,370
12,121,264
12,270,765
11,928,665
11,450,076
12,847,998
11,826,881
10,983,285
18,031,938
10,971,703
12,898,970
13,576,816
9,031,863
6,156,913
8,647,101
8,947,660
11,286,891
11,558,919
11,324,198
9,219,706
7,091,788
10,166,135
8,927,793
8,226,452
6,882,070
9,036,578
10,101,768
7,809,745
7,075,335
7,036,463
8,043,733
5,685,901
4,886,135
4,870,727
8,143,946
7,169,095
7,169,0958,143,9464,870,7274,886,1355,685,9018,043,7337,036,4637,075,3357,809,74510,101,7689,036,5786,882,0708,226,4528,927,79310,166,1357,091,7889,219,70611,324,19811,558,91911,286,8918,947,6608,647,1016,156,9139,031,86313,576,81612,898,97010,971,70318,031,93810,983,28511,826,88112,847,99811,450,07611,928,66512,270,76512,121,26414,391,37029,324,72829,878,71536,410,11625,259,99023,017,07921,039,852
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
13,000,000
6,000,000
6,000,000
6,000,000
6,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000006,000,0006,000,0006,000,0006,000,00013,000,0000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
13,000,000
6,000,000
6,000,000
6,000,000
6,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000006,000,0006,000,0006,000,0006,000,00013,000,0000000000000000
       Accounts payable 
4,468,552
4,916,759
4,351,465
7,427,159
4,836,868
6,071,814
5,564,801
3,026,540
2,926,986
3,045,125
2,364,382
3,674,644
2,323,332
1,907,584
2,844,090
3,003,309
3,246,179
2,454,626
4,024,771
2,060,703
3,400,713
2,201,527
3,768,245
3,765,122
4,605,458
3,455,148
3,446,526
5,253,835
3,966,810
4,199,169
3,321,453
4,137,337
5,837,636
3,835,685
3,849,835
0
3,668,827
2,422,784
1,585,942
1,116,442
2,670,889
0
02,670,8891,116,4421,585,9422,422,7843,668,82703,849,8353,835,6855,837,6364,137,3373,321,4534,199,1693,966,8105,253,8353,446,5263,455,1484,605,4583,765,1223,768,2452,201,5273,400,7132,060,7034,024,7712,454,6263,246,1793,003,3092,844,0901,907,5842,323,3323,674,6442,364,3823,045,1252,926,9863,026,5405,564,8016,071,8144,836,8687,427,1594,351,4654,916,7594,468,552
       Other Current Liabilities 
2,271,300
2,000,320
1,258,525
3,218,044
3,587,922
2,104,518
1,826,569
2,094,724
2,343,779
1,883,540
2,085,694
2,173,354
2,503,549
2,075,701
2,187,848
1,968,394
3,652,791
4,249,007
4,239,883
3,219,649
4,488,146
5,777,308
6,569,695
5,177,079
5,169,242
4,040,348
1,937,469
1,675,249
3,182,326
2,125,271
1,757,836
1,533,183
2,532,518
1,902,141
1,522,657
0
-1
0
0
0
0
0
00000-101,522,6571,902,1412,532,5181,533,1831,757,8362,125,2713,182,3261,675,2491,937,4694,040,3485,169,2425,177,0796,569,6955,777,3084,488,1463,219,6494,239,8834,249,0073,652,7911,968,3942,187,8482,075,7012,503,5492,173,3542,085,6941,883,5402,343,7792,094,7241,826,5692,104,5183,587,9223,218,0441,258,5252,000,3202,271,300
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,355,648
1,295,217
1,259,605
1,395,283
1,321,803
1,432,274
1,432,2741,321,8031,395,2831,259,6051,295,2171,355,648000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41,418
367,613
306,770
243,824
203,743
163,443
130,544
86,747
43,734
96,044
328,448
807,756
741,797
669,404
806,811
721,566
0
0
0
0
0000721,566806,811669,404741,797807,756328,44896,04443,73486,747130,544163,443203,743243,824306,770367,61341,4180000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
-13,000,000
-6,000,000
-6,000,000
-6,000,000
-6,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,015,118
0
1,169,094
1,086,383
1,038,206
1,229,516
1,135,390
0
01,135,3901,229,5161,038,2061,086,3831,169,09401,015,1180000000000000000-6,000,000-6,000,000-6,000,000-6,000,000-13,000,0000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
4,610,757
4,540,191
1,896,261
1,796,439
1,700,670
1,595,353
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000001,595,3531,700,6701,796,4391,896,2614,540,1914,610,7570000000000000
> Total Stockholder Equity
68,086,333
66,159,279
67,705,932
75,987,822
75,779,445
77,198,485
77,318,898
72,126,630
73,613,775
74,575,726
74,111,355
77,423,614
78,143,449
79,263,101
79,912,707
83,862,650
85,885,611
89,583,687
89,447,022
89,250,951
89,128,844
98,798,745
101,578,180
102,720,349
103,766,439
108,340,252
110,663,280
111,393,280
112,680,885
115,085,765
117,328,633
123,298,791
123,156,366
121,967,849
123,217,270
116,089,117
116,707,252
119,309,559
120,354,564
115,632,727
113,515,305
121,132,386
121,132,386113,515,305115,632,727120,354,564119,309,559116,707,252116,089,117123,217,270121,967,849123,156,366123,298,791117,328,633115,085,765112,680,885111,393,280110,663,280108,340,252103,766,439102,720,349101,578,18098,798,74589,128,84489,250,95189,447,02289,583,68785,885,61183,862,65079,912,70779,263,10178,143,44977,423,61474,111,35574,575,72673,613,77572,126,63077,318,89877,198,48575,779,44575,987,82267,705,93266,159,27968,086,333
   Common Stock
5,444,357
5,444,357
5,444,356
5,444,357
5,472,786
5,528,255
5,556,684
5,589,965
5,667,620
5,684,260
5,717,541
5,717,541
5,888,116
5,888,116
5,888,116
5,888,116
5,949,132
5,949,132
5,949,132
5,949,132
5,949,132
5,949,132
5,949,132
5,949,132
5,949,132
5,949,132
5,949,132
5,949,132
5,949,132
5,949,132
5,949,132
5,949,132
5,949,132
5,949,132
5,949,132
5,949,132
5,949,132
5,949,132
0
0
0
0
00005,949,1325,949,1325,949,1325,949,1325,949,1325,949,1325,949,1325,949,1325,949,1325,949,1325,949,1325,949,1325,949,1325,949,1325,949,1325,949,1325,949,1325,949,1325,949,1325,949,1325,949,1325,949,1325,888,1165,888,1165,888,1165,888,1165,717,5415,717,5415,684,2605,667,6205,589,9655,556,6845,528,2555,472,7865,444,3575,444,3565,444,3575,444,357
   Retained Earnings Total Equity000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,491,270
30,285,933
30,491,270
30,491,270
30,491,270
30,285,933
30,491,270
30,491,270
30,491,270
30,285,933
30,491,270
30,491,270
30,491,270
30,285,933
30,491,270
30,491,270
0
0
0
0
000030,491,27030,491,27030,285,93330,491,27030,491,27030,491,27030,285,93330,491,27030,491,27030,491,27030,285,93330,491,27030,491,27030,491,27030,285,93330,491,2700000000000000000000000
   Treasury Stock0000000000-1,876,705000-1,876,705000-1,876,7050000-1,876,705-1,876,705-1,876,705-1,876,705-1,876,705-1,876,705-1,876,705-1,200,293-822,629-822,629-822,629-822,629-822,629-822,629-822,629-1,095,230-1,095,230-1,095,230-1,095,230
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
-537
612
3,763,473
-203
-144
-3,171
-48,672
-45,335
-216,383
-2,093,035
-624,009
-380,818
-2,491,523
-612,525
-1,614,239
-1,608,583
-1,606,798
-1,599,199
-172,406
-169,962
-168,663
-164,840
292,745
-1,789,297
-1,848,899
0
0
0
0
0000-1,848,899-1,789,297292,745-164,840-168,663-169,962-172,406-1,599,199-1,606,798-1,608,583-1,614,239-612,525-2,491,523-380,818-624,009-2,093,035-216,383-45,335-48,672-3,171-144-2033,763,473612-5370000000000000



6.3. Balance Sheets

Currency in KRW. All numbers in thousands.




6.4. Cash Flows

Currency in KRW. All numbers in thousands.




6.5. Income Statements

Currency in KRW. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue64,214,831
Cost of Revenue-49,917,941
Gross Profit14,296,89014,296,890
 
Operating Income (+$)
Gross Profit14,296,890
Operating Expense-58,871,024
Operating Income5,343,807-44,574,134
 
Operating Expense (+$)
Research Development2,395,125
Selling General Administrative1,670,459
Selling And Marketing Expenses0
Operating Expense58,871,0244,065,584
 
Net Interest Income (+$)
Interest Income736,633
Interest Expense-38,284
Other Finance Cost-1
Net Interest Income698,348
 
Pretax Income (+$)
Operating Income5,343,807
Net Interest Income698,348
Other Non-Operating Income Expenses0
Income Before Tax (EBT)4,474,8185,343,807
EBIT - interestExpense = -38,284
3,823,643
3,861,927
Interest Expense38,284
Earnings Before Interest and Taxes (EBIT)04,513,102
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax4,474,818
Tax Provision-651,175
Net Income From Continuing Ops3,823,6433,823,643
Net Income3,823,643
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-698,348
 

Technical Analysis of Estechpharma
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Estechpharma. The general trend of Estechpharma is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Estechpharma's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of EstechPharma Co. Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6,440 < 6,650 < 6,650.

The bearish price targets are: 5,010.

Tweet this
EstechPharma Co. Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of EstechPharma Co. Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

EstechPharma Co. Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of EstechPharma Co. Ltd. The current macd is -180.65504377.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Estechpharma price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Estechpharma. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Estechpharma price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
EstechPharma Co. Ltd Daily Moving Average Convergence/Divergence (MACD) ChartEstechPharma Co. Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of EstechPharma Co. Ltd. The current adx is 21.59.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Estechpharma shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
EstechPharma Co. Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of EstechPharma Co. Ltd. The current sar is 5,428.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
EstechPharma Co. Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of EstechPharma Co. Ltd. The current rsi is 47.28. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
EstechPharma Co. Ltd Daily Relative Strength Index (RSI) ChartEstechPharma Co. Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of EstechPharma Co. Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Estechpharma price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
EstechPharma Co. Ltd Daily Stochastic Oscillator ChartEstechPharma Co. Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of EstechPharma Co. Ltd. The current cci is 32.08.

EstechPharma Co. Ltd Daily Commodity Channel Index (CCI) ChartEstechPharma Co. Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of EstechPharma Co. Ltd. The current cmo is 5.54153.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
EstechPharma Co. Ltd Daily Chande Momentum Oscillator (CMO) ChartEstechPharma Co. Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of EstechPharma Co. Ltd. The current willr is -54.89130435.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Estechpharma is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
EstechPharma Co. Ltd Daily Williams %R ChartEstechPharma Co. Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of EstechPharma Co. Ltd.

EstechPharma Co. Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of EstechPharma Co. Ltd. The current atr is 329.42.

EstechPharma Co. Ltd Daily Average True Range (ATR) ChartEstechPharma Co. Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of EstechPharma Co. Ltd. The current obv is 27,984,525.

EstechPharma Co. Ltd Daily On-Balance Volume (OBV) ChartEstechPharma Co. Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of EstechPharma Co. Ltd. The current mfi is 79.98.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
EstechPharma Co. Ltd Daily Money Flow Index (MFI) ChartEstechPharma Co. Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for EstechPharma Co. Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-11-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

EstechPharma Co. Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of EstechPharma Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.283
Ma 20Greater thanMa 505,721.000
Ma 50Greater thanMa 1006,379.400
Ma 100Greater thanMa 2006,883.100
OpenGreater thanClose5,930.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Estechpharma with someone you think should read this too:
  • Are you bullish or bearish on Estechpharma? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Estechpharma? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about EstechPharma Co. Ltd

I send you an email if I find something interesting about EstechPharma Co. Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about EstechPharma Co. Ltd.

Receive notifications about EstechPharma Co. Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.